CDC Recommends New Injectable HIV PrEP | CDC NCHHSTP
Sep 18, 2025 · Combined with HIV testing and effective treatment, PrEP has contributed to significant reductions in new HIV infections. Reaching people with more options for PrEP, …
What do we know about injectable HIV medication? - Aidsmap
In current guidelines, injections are an option for people who are already taking HIV treatment and have a viral load below 50. People may be able to switch to the injections if there is nothing in …
Injectables for HIV Treatment and Prevention: How They Work
Jul 15, 2025 · In January 2021, the U.S. Food and Drug Administration (FDA) approved an HIV treatment called Cabenuva. Cabenuva is a combination of cabotegravir and rilpivirine — both …
Information on HIV/AIDS Treatment, Prevention and Research
HIV/AIDS treatment and research information from the US federal government.
FDA Approves a Twice-Yearly Shot to Prevent HIV - TIME
Jun 20, 2025 · On June 18, the U.S. Food and Drug Administration (FDA) approved the first medicine to prevent HIV that only has to be taken twice a year. People who are at high risk for …
CABENVUA and VOCABRIA approved for HIV infection
Jan 27, 2021 · This is the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month.
Injectable HIV Treatments - H-I-V.net
Learn more about different HIV treatments including shots for the treatment of HIV and shots to help avoid the transmission of HIV.
Long-Acting HIV Treatment | CABENUVA (cabotegravir; rilpivirine)
CABENUVA is a complete prescription regimen used to treat HIV-1 infection in people 12 years and older who weigh at least 77 pounds. It is used as a replacement for their current HIV-1 …
Injectable HIV Treatment: Types, Benefits and Side Effects
May 31, 2024 · There are currently three separate HIV medications that are available to be taken by injection: Cabenuva (cabotegravir + rilpivirine), Sunlenca (lenacapavir), and Trogarzo …
WHO recommends injectable lenacapavir for HIV prevention
Jul 14, 2025 · The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre …